American Heart Association
The American Heart Association has extended the deadline for individual scholarships and school grants offered through Kids Heart Challenge and American Heart Challenge to June 30.
With COVID-19 incidence currently increasing exponentially worldwide, the percentage of cardiac arrests with COVID-19 are also likely to increase.
Research to help increase awareness of the cardiovascular manifestations of COVID-19 disease and the adverse impact of cardiovascular involvement on prognosis was published late yesterday in Circulation, the flagship journal of the American Heart Association.
We’ve convened a team of incredible fitness instructors/experts to take over the American Heart Association Facebook and YouTube pages every Monday through Friday, 9:00 a.m. and 9:00 p.m. ET, to guide us through living room-friendly virtual workouts, including sessions on stretching, yoga and Pilates.
As part of its global response to the growing COVID-19 pandemic, the American Heart Association, the world’s leading voluntary organization focused on heart and brain health and research, is committing $2.5 million to research efforts to better understand this unique coronavirus and its interaction with the body’s cardiovascular and cerebrovascular systems.
Use of antihypertensive medications and statins for the primary prevention of cardiovascular disease (CVD) has expanded over the past few decades1–3 and may increase further in response to recent guideline changes.
Disruption of protein homeostasis has significant consequences in cells. In particular, accumulation of misfolded proteins is cytotoxic and leads to the development of numerous diseases.
Coronary microvascular dysfunction (MVD) is defined by impaired flow augmentation in response to a pharmacological vasodilator in the presence of nonobstructive coronary artery disease.
Stay Up-To-Date on jobs and industry news.
Sign up for the CathLab.com newsletter today!